Who should be offered the quadrivalent meningococcal polysaccharide vaccine?

Updated: Jul 16, 2019
  • Author: Rodrigo Hasbun, MD, MPH; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print

Vaccination with quadrivalent meningococcal polysaccharide vaccine should be offered to all high-risk populations, including those who have underlying immune deficiencies, those who travel to hyperendemic areas and epidemic areas, and those who do laboratory work that involves routine exposure to N meningitidis. College students who live in dormitories or residence halls are at modest risk; they should be informed about the risk and offered vaccination.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!